午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

(+/-)-trans-4-(3-hydroxy-phenyl)-pyrrolidine-3-carboxylic acid

(+/-)-trans-4-(3-hydroxy-phenyl)-pyrrolidine-3-carboxylic acid Struktur
1392266-44-2
CAS-Nr.
1392266-44-2
Englisch Name:
(+/-)-trans-4-(3-hydroxy-phenyl)-pyrrolidine-3-carboxylic acid
Synonyma:
(3R,4S)-rel-4-(3-Methoxyphenyl)pyrrolidine-3-carboxylic acid;rel-(3R,4S)-4-(3-Methoxyphenyl)-3-pyrrolidinecarboxylic acid;(+/-)-trans-4-(3-hydroxy-phenyl)-pyrrolidine-3-carboxylic acid;(+/-)-trans-4-(3-hydroxy-phenyl)-pyrrolidine-3-carboxylic acid;3-Pyrrolidinecarboxylic acid, 4-(3-methoxyphenyl)-, (3R,4S)-rel-
CBNumber:
CB52654916
Summenformel:
C12H15NO3
Molgewicht:
221.25
MOL-Datei:
1392266-44-2.mol

(+/-)-trans-4-(3-hydroxy-phenyl)-pyrrolidine-3-carboxylic acid Eigenschaften

Sicherheit

(+/-)-trans-4-(3-hydroxy-phenyl)-pyrrolidine-3-carboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

(+/-)-trans-4-(3-hydroxy-phenyl)-pyrrolidine-3-carboxylic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(+/-)-trans-4-(3-hydroxy-phenyl)-pyrrolidine-3-carboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Nextpeptide Inc 		+86-0571-81612335 +8613336028439
 sales@nextpeptide.com China 19908 58
Shanghai Haohong Pharmaceutical Co., Ltd. 4008210725 4008210725
 malulu@leyan.com China 54987 58
SINO High Goal Chemical Technology Co., Ltd. 021-57646680 18306277365
 guoxin@chembiobanksh.com China 2564 58
Shanghai Yanbang Pharmaceutical Technology Co., Ltd 15618536883
 1228181347@qq.com China 7988 58
  • (+/-)-trans-4-(3-hydroxy-phenyl)-pyrrolidine-3-carboxylic acid
  • 3-Pyrrolidinecarboxylic acid, 4-(3-methoxyphenyl)-, (3R,4S)-rel-
  • (3R,4S)-rel-4-(3-Methoxyphenyl)pyrrolidine-3-carboxylic acid
  • (+/-)-trans-4-(3-hydroxy-phenyl)-pyrrolidine-3-carboxylic acid
  • rel-(3R,4S)-4-(3-Methoxyphenyl)-3-pyrrolidinecarboxylic acid
  • 1392266-44-2
Copyright 2019 ? ChemicalBook. All rights reserved